跳至主要内容
临床试验/NCT02504957
NCT02504957已完成不适用

Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction - a Retrospective Analysis.

Medical University of Vienna0 个研究点目标入组 88 人开始时间: 2015年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88
主要终点
Safety of photodynamic therapy

研究概览

简要总结

Photodynamic therapy (PDT) is a palliative treatment for malignant biliary obstruction. The aim of this study is to assess the feasibility and safety of this technique in the context of a nationwide retrospective analysis.

详细描述

INTRODUCTION

Malignant biliary obstruction is a life threatening condition in patients suffering from primary or secondary bile duct malignancies. Palliative therapies aim to prevent complications associated with the obstruction. Photodynamic therapy (PDT) aims to reduce the local tumor mass by inducing tumor necrosis after light activation of a photosensitizer during endoscopic retrograde cholangiography (ERC).

STUDY AIMS

The aim of the present study is to evaluate the feasibility and safety of PDT with polyhematoporphyrin, the photosensitizer most commonly used for PDT in Austria, in the context of a nationwide analysis.

METHODS

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Undergone photodynamic therapy as a treatment for malignant biliary obstruction.

排除标准

  • 未提供

结局指标

主要结局

Safety of photodynamic therapy

时间窗: 30 days

Treatment emergent adverse events

次要结局

  • Efficacy of photodynamic therapy(From date of first photodynamic therapy until date of death from any cause, assessed up to 100 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Werner Dolak, MD

Assistant doctor

Medical University of Vienna

相似试验

Photodynamic Therapy With Polyhematoporphyrin for... | 临床试验